Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell activation via antigen-presenting cells (APCs) is a central process in the adaptive immune response. It involves the recognition of antigens by T cells, which are presented on the surface of APCs bound to major histocompatibility complex (MHC) molecules. This interaction triggers a cascade of intracellular signaling events that lead to T cell proliferation, differentiation, and effector function. The activation process requires two main signals: antigen recognition (TCR binding to MHC-peptide) and co-stimulation (e.g., CD28-CD80/86 interaction). Upon successful engagement, intracellular kinases are activated, gene transcription programs initiate, and cytokine production begins, driving clonal expansion and differentiation. Dysregulation can result in autoimmunity or immunodeficiency. Therapeutic modulation focuses on co-stimulatory pathways and cytokine signaling for treating autoimmune diseases and cancer.
Modulation of T cell co-stimulatory signals or cytokine signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T Cell Activation via Antigen-Presenting Cells (T Cell Activation).